𝔖 Bobbio Scriptorium

✦ LIBER ✦

Complement-mediated tumour growth: Implications for cancer nanotechnology and nanomedicines

✍ Scribed by S.M. Moghimi; T.L. Andresen

Book ID: 116757283
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 117 KB
Volume: 46
Category: Article
ISSN: 0161-5890
DOI: 10.1016/j.molimm.2009.02.014

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cancer nanomedicine and the complement s

Cancer nanomedicine and the complement system activation paradigm: Anaphylaxis and tumour growth

✍ Moghimi, S.M. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 906 KB

Tumour growth is more dispersed in pancr

Tumour growth is more dispersed in pancreatic head cancers than in rectal cancer: implications for resection margin assessment

✍ Caroline Sophie Verbeke; Johannes Knapp; Ivar Prydz Gladhaug 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 732 KB

Prebiopsy neo-adjuvant endocrine therapy

Prebiopsy neo-adjuvant endocrine therapy for breast cancer to prevent post-surgery trauma-induced growth factor and immune-suppression mediated tumour progression

✍ R.T.D. Oliver; J. Tobias; C. Gallagher 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 233 KB

Letters to the editor: Comments on Prebi

Letters to the editor: Comments on Prebiopsy neoadjuvant endocrine therapy for breast cancer to prevent post-surgery trauma-induced growth factor and immune-suppression mediated tumour progression, oliver et al., EurJ cancer, 32A, No. 3, pp. 396–397, 1996

✍ K. Mokbel 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 132 KB

Letters to the editor: Comments on Prebi

Letters to the editor: Comments on Prebiopsy neoadjuvant endocrine therapy for breast cancer to prevent post-surgery trauma-induced growth factor and immune-suppression mediated tumour progression, oliver et al., Eurj cancer, 32A, No. 3, pp. 396–397, 1996

✍ R.T.D. Oliver 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 273 KB